Expiring Contracts — NAICS 325412

PHARMACEUTICAL PREPARATION MANUFACTURING

682 contracts with NAICS code 325412 expiring within the next 18 months.

Showing 201-225 of 682 results
15B51926P00000024166 days remaining

B3-26-01 OPEN MKT PO 3704

MCKESSON CORPORATION|Department of Justice|Expires Sep 30, 2026
15B10626P00000058166 days remaining

PETNET: ISOTOPES FOR PET SCANS DOS: OCTOBER 1, 2025 THRU SEPTEMBER 30, 2026 FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE AND/OR WHEN THE BUDGET IS PASSED.

PETNET SOLUTIONS, INC.|Department of Justice|Expires Sep 30, 2026
15B30525F00000044166 days remaining

FY26 INMATE MEDICATION

MCKESSON CORPORATION|Department of Justice|Expires Sep 30, 2026
$15,500
75N90026F00006166 days remaining

PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

PROGENICS PHARMACEUTICALS INC|Department of Health and Human Services|Expires Sep 30, 2026
$163,192.4
36C24926F0045166 days remaining

PYLARIFY

PROGENICS PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Sep 30, 2026
$674,830.64
HT009026FG1110036166 days remaining

PHARMACEUTICALS NEEDED FOR PATIENT CARE.

SOFIE CO.|Department of Defense|Expires Sep 30, 2026
$36,087.2
36C24826N0051166 days remaining

DATSCAN AND VIZAMYL

MEDI-PHYSICS, INC.|Department of Veterans Affairs|Expires Sep 30, 2026
$483,490.85
36C25626N0061166 days remaining

RADIOPHAMACEUTICAL SUPPLIES

NUMEDRX PHARMACY SOLUTIONS LLC|Department of Veterans Affairs|Expires Sep 30, 2026
$597,345.84
36C26126F0008166 days remaining

LUTATHERA CANCER THERAPY

NOVARTIS PHARMACEUTICALS CORPORATION|Department of Veterans Affairs|Expires Sep 30, 2026
$679,948.64
36C25026F0012166 days remaining

GENERAL NUC MED RX DOSE ADDITIONS OF DETECTNET AND LYMPHOSEEK RADIOPHARM GENERAL RX

CARDINAL HEALTH 414, LLC|Department of Veterans Affairs|Expires Sep 30, 2026
$537,758.88
36C24926N0018166 days remaining

VARIOUS RADIOPHARMACEUTICALS INC EXERCISE OPTION YEAR 2

CARDINAL HEALTH 414, LLC|Department of Veterans Affairs|Expires Sep 30, 2026
$818,504.34
36C26026F0006166 days remaining

PHARM - ORLADEYO

BIOCRYST PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Sep 30, 2026
$360,000
36C26026F0022166 days remaining

PHARM - ICLUSIG

TAKEDA PHARMACEUTICALS AMERICA, INC.|Department of Veterans Affairs|Expires Sep 30, 2026
$56,789.56
36C26026F0020166 days remaining

PHARM - VYALEV

ABBVIE US LLC|Department of Veterans Affairs|Expires Sep 30, 2026
$164,749.44
36C26026F0037166 days remaining

PROLASTIN-C LIQUID,HUMAN 1000MG/VIL.

GRIFOLS USA LLC|Department of Veterans Affairs|Expires Sep 30, 2026
$363,999.71
36C24926N0007166 days remaining

PYLARIFY 18 5 YEAR ORDERING PERIOD

PHARMALOGIC HOLDINGS CORP.|Department of Veterans Affairs|Expires Sep 30, 2026
$469,133.6
36C24824P1262166 days remaining

LIASON QUANTIFERON-TB GOLD PLUSE US & CONTROL QUANTIFERON-TB GOLD PLUS.

QIAGEN, LLC|Department of Veterans Affairs|Expires Sep 30, 2026
$101,595.89
15B51926F00000011166 days remaining

CONTINUITY OF CARE

MCKESSON CORPORATION|Department of Justice|Expires Sep 30, 2026
15B50526F00000032166 days remaining

FY 26 STANDARD MEDICATION

MCKESSON CORPORATION|Department of Justice|Expires Sep 30, 2026
$1.0M
36C26226N0239166 days remaining

THERASPHERE Y-90

BOSTON SCIENTIFIC CORP|Department of Veterans Affairs|Expires Sep 30, 2026
$693,000
15B51926F00000016166 days remaining

REGULAR PO 3707

MCKESSON CORPORATION|Department of Justice|Expires Sep 30, 2026
W81K0225FA144166 days remaining

Y-90 GLASS THERASPHERES

BOSTON SCIENTIFIC CORP|Department of Defense|Expires Sep 30, 2026
$66,000
15B30525F00000044166 days remaining

FY26 INMATE MEDICATION

MCKESSON CORPORATION|Department of Justice|Expires Sep 30, 2026
$15,500
75N90026F00006166 days remaining

PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

PROGENICS PHARMACEUTICALS INC|Department of Health and Human Services|Expires Sep 30, 2026
$348,837.12
HT009026FG1110036166 days remaining

PHARMACEUTICALS NEEDED FOR PATIENT CARE.

SOFIE CO.|Department of Defense|Expires Sep 30, 2026
$36,087.2